{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:56Z","timestamp":1772120036473,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12149-025-02059-y","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T10:48:56Z","timestamp":1747133336000},"page":"943-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A first-in-man PET study of 2-amino-[3-11C] isobutyric acid for the amino acid transport System A: biodistribution and dosimetry in healthy volunteers"],"prefix":"10.1007","volume":"39","author":[{"given":"Kentaro","family":"Tamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi B.","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-4737","authenticated-orcid":false,"given":"Tatsuya","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2059_CR1","first-page":"235","volume":"43","author":"NC Gupta","year":"1993","unstructured":"Gupta NC, Frick MP. Clinical applications of positron-emission tomography in cancer. CA Cancer J Clin. 1993;43:235\u201354.","journal-title":"CA Cancer J Clin"},{"key":"2059_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fchem.2017.00124","volume":"5","author":"A Sun","year":"2017","unstructured":"Sun A, Liu X, Tang G. Carbon-11 and fluorine-18 labeled amino acid tracers for positron emission tomography imaging of tumors. Front Chem. 2017;5:124.","journal-title":"Front Chem"},{"key":"2059_CR3","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","volume":"75","author":"YD Bhutia","year":"2015","unstructured":"Bhutia YD, Babu E, Ramachandran S, Ganapathy V. Amino Acid transporters in cancer and their relevance to \u201cglutamine addiction\u201d: novel targets for the design of a new class of anticancer drugs. Cancer Res. 2015;75:1782\u20138.","journal-title":"Cancer Res"},{"key":"2059_CR4","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36:1302\u201315.","journal-title":"EMBO J"},{"key":"2059_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang L, Venneti S, Nagrath D. Glutaminolysis: a hallmark of cancer metabolism. Annu Rev Biomed Eng. 2017;19:163\u201394.","journal-title":"Annu Rev Biomed Eng"},{"key":"2059_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52:1496\u2013516.","journal-title":"Exp Mol Med"},{"key":"2059_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35:427\u201333.","journal-title":"Trends Biochem Sci"},{"key":"2059_CR8","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.bbamcr.2015.12.017","volume":"1863","author":"YD Bhutia","year":"2016","unstructured":"Bhutia YD, Ganapathy V. Glutamine transporters in mammalian cells and their functions in physiology and cancer. Biochim Biophys Acta. 2016;1863:2531\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"2059_CR9","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","volume":"291","author":"A Br\u00f6er","year":"2016","unstructured":"Br\u00f6er A, Rahimi F, Br\u00f6er S. Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells. J Biol Chem. 2016;291:13194\u2013205.","journal-title":"J Biol Chem"},{"key":"2059_CR10","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1074\/jbc.RA118.006378","volume":"294","author":"A Br\u00f6er","year":"2019","unstructured":"Br\u00f6er A, Gauthier-Coles G, Rahimi F, van Geldermalsen M, Dorsch D, Wegener A, et al. Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells. J Biol Chem. 2019;294:4012\u201326.","journal-title":"J Biol Chem"},{"key":"2059_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41416-020-01113-y","volume":"124","author":"M Morotti","year":"2021","unstructured":"Morotti M, Zois CE, El-Ansari R, Craze ML, Rakha EA, Fan S-J, et al. Increased expression of glutamine transporter SNAT2\/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. Br J Cancer. 2021;124:494\u2013505.","journal-title":"Br J Cancer"},{"key":"2059_CR12","doi-asserted-by":"publisher","first-page":"20322","DOI":"10.1002\/jcp.28632","volume":"234","author":"Y Li","year":"2019","unstructured":"Li Y, Shao H, Da Z, Pan J, Fu B. High expression of SLC38A1 predicts poor prognosis in patients with de novo acute myeloid leukemia. J Cell Physiol. 2019;234:20322\u20138.","journal-title":"J Cell Physiol"},{"key":"2059_CR13","first-page":"81","volume":"31","author":"N Kondoh","year":"2007","unstructured":"Kondoh N, Imazeki N, Arai M, Hada A, Hatsuse K, Matsuo H, et al. Activation of a system A amino acid transporter, ATA1\/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. Int J Oncol. 2007;31:81\u20137.","journal-title":"Int J Oncol"},{"key":"2059_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11596-017-1690-3","volume":"37","author":"F-F Zhou","year":"2017","unstructured":"Zhou F-F, Xie W, Chen S-Q, Wang X-K, Liu Q, Pan X-K, et al. SLC38A1 promotes proliferation and migration of human colorectal cancer cells. J Huazhong Univ Sci Technol Med Sci. 2017;37:30\u20136.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"2059_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1471-2407-13-343","volume":"13","author":"K Wang","year":"2013","unstructured":"Wang K, Cao F, Fang W, Hu Y, Chen Y, Ding H, et al. Activation of SNAT1\/SLC38A1 in human breast cancer: correlation with p-Akt overexpression. BMC Cancer. 2013;13:343.","journal-title":"BMC Cancer"},{"key":"2059_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092151","author":"I B\u00f6hme-Sch\u00e4fer","year":"2022","unstructured":"B\u00f6hme-Sch\u00e4fer I, L\u00f6rentz S, Bosserhoff AK. Role of amino acid transporter SNAT1\/SLC38A1 in human melanoma. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14092151.","journal-title":"Cancers"},{"key":"2059_CR17","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2015.447","volume":"35","author":"L Jin","year":"2016","unstructured":"Jin L, Alesi GN, Kang S. Glutaminolysis as a target for cancer therapy. Oncogene. 2016;35:3619\u201325.","journal-title":"Oncogene"},{"key":"2059_CR18","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0021-9258(18)60309-6","volume":"237","author":"HN Christensen","year":"1962","unstructured":"Christensen HN, Jones JC. Amino acid transport models: renal resorption and resistance to metabolic attack. J Biol Chem. 1962;237:1203\u20136.","journal-title":"J Biol Chem"},{"key":"2059_CR19","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1126\/science.126.3281.1002","volume":"126","author":"MW Noall","year":"1957","unstructured":"Noall MW, Riggs TR, Walker LM, Christensen HN. Endocrine control of amino acid transfer; distribution of an unmetabolizable amino acid: distribution of an unmetabolizable amino acid. Science. 1957;126:1002\u20135.","journal-title":"Science"},{"key":"2059_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0021-9258(19)68042-7","volume":"233","author":"TR Riggs","year":"1958","unstructured":"Riggs TR, Walker LM. Diminished uptake of C14-\u03b1-aminoisobutyric acid by tissues of vitamin B6-deficient rats. J Biol Chem. 1958;233:132\u20137.","journal-title":"J Biol Chem"},{"key":"2059_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0047-0740(84)90001-9","volume":"11","author":"B Schmall","year":"1984","unstructured":"Schmall B, Conti PS, Bigler RE, Zanzonico PB, Dahl JR, Sundoro-Wu BM, et al. Synthesis and quality assurance of [11C]alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissues. Int J Nucl Med Biol. 1984;11:209\u201314.","journal-title":"Int J Nucl Med Biol"},{"key":"2059_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF00261763","volume":"10","author":"RE Bigler","year":"1985","unstructured":"Bigler RE, Zanzonico PB, Schmall B, Conti PS, Dahl JR, Rothman L, et al. Evaluation of [1-11C]-alpha-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies. Eur J Nucl Med. 1985;10:48\u201355.","journal-title":"Eur J Nucl Med"},{"key":"2059_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00261762","volume":"10","author":"PS Conti","year":"1985","unstructured":"Conti PS, Sordillo EM, Sordillo PP, Schmall B. Tumor localization of alpha-aminoisobutyric acid (AIB) in human melanoma heterotransplants. Eur J Nucl Med. 1985;10:45\u20137.","journal-title":"Eur J Nucl Med"},{"key":"2059_CR24","first-page":"172","volume":"6","author":"PP Sordillo","year":"1991","unstructured":"Sordillo PP, DiResta GR, Fissekis J, Conti P, Benua RS, Yeh SD, et al. Tumor imaging with carbon-11 labeled alpha-aminoisobutyric acid (AIB) in patients with malignant melanoma. Am J Physiol Imaging. 1991;6:172\u20135.","journal-title":"Am J Physiol Imaging"},{"key":"2059_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00003072-198701000-00005","volume":"12","author":"B Schmall","year":"1987","unstructured":"Schmall B, Conti PS, Bigler RE, Zanzonico PB, Reiman RE, Benua RS, et al. Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med. 1987;12:22\u20136.","journal-title":"Clin Nucl Med"},{"key":"2059_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0969-8051(95)02065-9","volume":"23","author":"B Schmall","year":"1996","unstructured":"Schmall B, Conti PS, Alauddin MM. Synthesis of [11C-methyl]-alpha-aminoisobutyric acid (AIB). Nucl Med Biol. 1996;23:263\u20136.","journal-title":"Nucl Med Biol"},{"key":"2059_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00259-002-1010-3","volume":"30","author":"E Sutinen","year":"2003","unstructured":"Sutinen E, Jyrkki\u00f6 S, Alanen K, N\u00e5gren K, Minn H. Uptake of [N-methyl-11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med Mol Imaging. 2003;30:72\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2059_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s12149-013-0750-4","volume":"27","author":"R Nishii","year":"2013","unstructured":"Nishii R, Higashi T, Kagawa S, Kishibe Y, Takahashi M, Yamauchi H, et al. Diagnostic usefulness of an amino acid tracer, \u03b1-[N-methyl-(11)C]-methylaminoisobutyric acid (11)C-MeAIB), in the PET diagnosis of chest malignancies. Ann Nucl Med. 2013;27:808\u201321.","journal-title":"Ann Nucl Med"},{"key":"2059_CR29","first-page":"1235","volume":"51","author":"R Nishii","year":"2010","unstructured":"Nishii R, Higashi T, Kagawa S, Kishibe Y, Takahashi M, Kobayashi M, et al. Assessment of efficacy of [11C]-MeAIB PET as a biomarker of the system A amino acid transport: Comparison with [11C]-MET PET and [18F]-FDG PET in the patients with glioblastoma multiforme. J Nucl Med. 2010;51:1235\u20131235.","journal-title":"J Nucl Med"},{"key":"2059_CR30","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00259-002-0921-3","volume":"29","author":"MR Asola","year":"2002","unstructured":"Asola MR, Virtanen KA, Peltoniemi P, N\u00e5gren K, Yu M, Mattila K, et al. Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET. Eur J Nucl Med Mol Imaging. 2002;29:1485\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2059_CR31","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.bmcl.2011.02.065","volume":"21","author":"K Kato","year":"2011","unstructured":"Kato K, Tsuji AB, Saga T, Zhang M-R. An efficient and expedient method for the synthesis of 11C-labeled \u03b1-aminoisobutyric acid: a tumor imaging agent potentially useful for cancer diagnosis. Bioorg Med Chem Lett. 2011;21:2437\u201340.","journal-title":"Bioorg Med Chem Lett"},{"key":"2059_CR32","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/MNM.0b013e328356efb0","volume":"33","author":"AB Tsuji","year":"2012","unstructured":"Tsuji AB, Kato K, Sugyo A, Okada M, Sudo H, Yoshida C, et al. Comparison of 2-amino-[3-11C]isobutyric acid and 2-deoxy-2-[18F]fluoro-D-glucose in nude mice with xenografted tumors and acute inflammation. Nucl Med Commun. 2012;33:1058\u201364.","journal-title":"Nucl Med Commun"},{"key":"2059_CR33","first-page":"2737","volume":"53","author":"H Sudo","year":"2018","unstructured":"Sudo H, Tsuji AB, Sugyo A, Okada M, Kato K, Zhang M, et al. Direct comparison of 2-amino[3-11C]isobutyric acid and 2-amino[11C]methyl-isobutyric acid uptake in eight lung cancer xenograft models. Int J Oncol. 2018;53:2737\u201344.","journal-title":"Int J Oncol"},{"key":"2059_CR34","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.3892\/or.2015.3868","volume":"33","author":"AB Tsuji","year":"2015","unstructured":"Tsuji AB, Sugyo A, Sudo H, Suzuki C, Wakizaka H, Zhang M-R, et al. Preclinical assessment of early tumor response after irradiation by positron emission tomography with 2-amino-[3-11C]isobutyric acid. Oncol Rep. 2015;33:2361\u20137.","journal-title":"Oncol Rep"},{"issue":"2\u20134","key":"2059_CR35","first-page":"1","volume":"37","author":"ICRP","year":"2007","unstructured":"ICRP. Recommendations of the International Commission on Radiological Protection. Ann ICRP. 2007;37(2\u20134):1\u2013332.","journal-title":"Ann ICRP"},{"key":"2059_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s002590100548","volume":"28","author":"E Sutinen","year":"2001","unstructured":"Sutinen E, Jyrkki\u00f6 S, Gr\u00f6nroos T, Haaparanta M, Lehikoinen P, N\u00e5gren K. Biodistribution of [11C] methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo. Eur J Nucl Med. 2001;28:847\u201354.","journal-title":"Eur J Nucl Med"},{"key":"2059_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0969-8051(96)00073-X","volume":"23","author":"JR Bading","year":"1996","unstructured":"Bading JR, Kan-Mitchell J, Conti PS. System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET. Nucl Med Biol. 1996;23:779\u201386.","journal-title":"Nucl Med Biol"},{"key":"2059_CR38","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s00259-006-0096-4","volume":"33","author":"T Tolvanen","year":"2006","unstructured":"Tolvanen T, N\u00e5gren K, Yu M, Sutinen E, Havu-Aur\u00e9n K, Jyrkki\u00f6 S, et al. Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport. Eur J Nucl Med Mol Imaging. 2006;33:1178\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2059_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s002590050265","volume":"25","author":"HM Deloar","year":"1998","unstructured":"Deloar HM, Fujiwara T, Nakamura T, Itoh M, Imai D, Miyake M, et al. Estimation of internal absorbed dose of L-[methyl-11C]methionine using whole-body positron emission tomography. Eur J Nucl Med. 1998;25:629\u201333.","journal-title":"Eur J Nucl Med"},{"key":"2059_CR40","unstructured":"U.S. Food and Drug Administration. Code of Federal Regulations, Title 21 Food and drugs, Part 361 prescription drugs for human use generally recognized as safe and effective and not misbranded: drug used in research, Sec. 361.1 Radioactive drugs for certain research uses. 2016"},{"key":"2059_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0146-6453(91)90019-D","volume":"22","author":"Radiological Protection in Biomedical Research","year":"1991","unstructured":"Radiological Protection in Biomedical Research. A report of Committee 3 adopted by the International Commission on Radiological Protection. Ann ICRP. 1991;22:1\u201328.","journal-title":"Ann ICRP"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02059-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:46:01Z","timestamp":1757169961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02059-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2059"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02059-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6203099\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}